Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.77
Delayed Data
As of May 22
 +0.12 / +3.29%
Today’s Change
3.00
Today|||52-Week Range
4.69
+14.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-4.6M-17.9M-13.1M-13.4M
 
 
 
 
 
Depreciation6.6K6.0K3.4K1.0K
 
 
 
 
 
Total Other Cash Flow1.5M15.9M9.2M6.4M
 
 
 
 
 
Funds From Operations-3.1M-2.0M-3.9M-7.0M
 
 
 
 
 
Funds From/For Other Operating Expenses2.4M1.7M586.2K-773.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-5.5M-3.8M-4.5M-6.2M
 
 
 
 
 
 
InvestingCapital Expenditures-3.5K0.00-1.8K0.00
 
 
 
Net Cash Flow Investing-3.5K0.00-1.8K0.00
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings944.3K0.000.000.00
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale5.1M3.5M6.1M5.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00----0.00--
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing----0.000.00--
Other Uses - Financing181.0K43.1K0.000.00
 
 
 
Net Cash Flow - Financing5.9M3.5M6.1M5.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash336.8K-257.8K1.6M-1.2M